Financhill
Back

Standard BioTools Quote, Financials, Valuation and Earnings

Standard BioTools Price Quote

$1.60

Standard BioTools Key Stats

Sell
41
Standard BioTools (LAB) is a Sell

Day range:
$1.58 - $1.67
52-week range:
$1.21 - $3.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.87
P/B ratio:
1.22%

Volume:
1.4M
Avg. volume:
2.2M
1-year change:
-32.49%
Market cap:
$595.6M
Revenue:
$106.3M
EPS:
$-0.71

How Much Does Standard BioTools Make?

Is Standard BioTools Growing As A Company?

  • What Is Standard BioTools's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.77%
  • What Is Standard BioTools's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Standard BioTools Stock Price Performance

  • Did Standard BioTools Stock Go Up Last Month?
    Standard BioTools share price went down by -13.04% last month
  • Did LAB's Share Price Rise Over The Last Year?
    LAB share price fell by -32.49% over the past 1 year

What Is Standard BioTools 52-Week High & Low?

Standard BioTools Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Standard BioTools?

  • How Much Debt Does Standard BioTools Have?
    Total long term debt quarterly is $55.2M
  • How Much Cash Does Standard BioTools Have?
    Cash and short term investments quarterly total is $366.3M
  • What Is Standard BioTools’s Book Value Per Share?
    Book value per share is 1.31

Is Standard BioTools Cash Flow Positive?

  • What Is LAB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$143.5M
  • What Is Standard BioTools’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$49.1M
  • What Is Standard BioTools’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $324.3M

Standard BioTools Return On Invested Capital

  • Is Management Doing A Good Job?
    LAB return on invested capital is -39.17%
  • What Is Standard BioTools Return On Assets?
    ROA measures how assets are converting to revenues and is -22.01%
  • What Is LAB Return On Equity?
    ROE is a measure of profitability and is -48.03%

Standard BioTools Earnings Date & Stock Price

Standard BioTools Competitors

Standard BioTools Dividend Yield

Standard BioTools Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 53.87%
Revenue: 77.27% 9.68%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.08
Upside from Last Price: 92.71%

Major Shareholders

  • How many LAB shares are owned by institutional investors?
    386.5M LAB shares are owned by institutional investors
  • How many LAB shares are owned by insiders?
    7.6M LAB shares are owned by insiders